HR 5988 117th Congress House International Affairs Asia Cardiovascular and respiratory health China Congressional oversight Department of Health and Human Services Drug trafficking and controlled substances Government employee pay, benefits, personnel management Government ethics and transparency, public corruption Government studies and investigations Health programs administration and funding Infectious and parasitic diseases Medical research National Institutes of Health (NIH) Public contracts and procurement Research administration and funding World health

FAUCI Act

Introduced: November 16, 2021 See on congress.gov

Everywhere this bill has been 3 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Nov 17, 2021

Referred to the Subcommittee on Health.

Nov 16, 2021

Introduced in House

Nov 16, 2021

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Science, Space, and Technology, Oversight and Reform, and Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Fairness and Accountability in Underwriting Chinese Institutions Act or the FAUCI Act

This bill prohibits making any federal funding available to laboratories or research institutions in China for gain-of-function research. The President may waive this prohibition for national security interests. (Under the bill, gain-of-function research generally involves the enhancement of potential pandemic pathogens or related risky research with potentially dangerous pathogens.)

Furthermore, if the Office of the Inspector General of the Department of Health and Human Services determines that a National Institutes of Health official, employee, or grantee has intentionally misled or omitted information in a relevant disclosure (e.g., to Congress) about federal funding for international gain-of-function research, such a person shall be ineligible for any federal funding or federal employment.

What's happening now November 17, 2021

Referred to the Subcommittee on Health.

Related & companion bills 1

Bill text 1 version